Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haim Erder

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|March 7, 2014
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care populationTara K Knight, Aniket Kawatkar, Paul Hodgkins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
European Child & Adolescent Psychiatry|October 30, 2013
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference caseHoa H Le, Paul Hodgkins, Maarten J Postma, et al.
Journal of Medical Economics|April 16, 2019
Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment responseRegina Grebla, Juliana Setyawan, Chanhyun Park, et al.
Journal of Medical Economics|June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costsAndrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.
Applied Health Economics and Health Policy|November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonM Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of the American Medical Directors Association|October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's diseaseHoward Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
CNS Drugs|August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodologyVanja Sikirica, Robert L Findling, James Signorovitch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness researchJames E Signorovitch, Vanja Sikirica, M Haim Erder, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|March 7, 2014
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care populationTara K Knight, Aniket Kawatkar, Paul Hodgkins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 2, 2012
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi, Paul Hodgkins, Jennifer Kahle, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
European Child & Adolescent Psychiatry|October 30, 2013
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference caseHoa H Le, Paul Hodgkins, Maarten J Postma, et al.
Journal of Medical Economics|April 16, 2019
Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment responseRegina Grebla, Juliana Setyawan, Chanhyun Park, et al.
Journal of Medical Economics|June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costsAndrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.
Applied Health Economics and Health Policy|November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparisonM Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of the American Medical Directors Association|October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's diseaseHoward Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
CNS Drugs|August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodologyVanja Sikirica, Robert L Findling, James Signorovitch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness researchJames E Signorovitch, Vanja Sikirica, M Haim Erder, et al.
Pageof 7